FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)

View source ↗

Summary

The FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector, updating/expanding its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nerve Agent Exposure
• Organophosphate Poisoning

Drugs mentioned

• ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR (ATROPINE AND PRALIDOXIME CHLORIDE)

Snippet

SUPPL AP for ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR (ATROPINE AND PRALIDOXIME CHLORIDE)